Home - Cancer Research - A peer reviewed journal that is a breed apart is Oncotarget.

A peer reviewed journal that is a breed apart is Oncotarget.

Posted on March 6, 2017 in Cancer Research

Oncology or the study of tumors is a very complicated subject. Finding information on cancer can be very difficult. Luckily, there is one company that researches tumors and simplifies finding information. They even publish their findings online for free every week. That company’s name is Oncotarget. Oncotarget is a peer-reviewed journal that is a subsidiary of Impact Journals. They have published many articles on cancer research and a variety of other subjects. The research they publish is on endocrinology, pathology, immunology, and of course oncology. Their primary focus is still on Oncology studies although they are branching out and researching other subjects.

Download output styles at Endnote.com.

It’s editor are chief are Andrei V. Gudkov and Mikhail Blagosklonny. They work with the company to study the aging process and its effects on the human body. The company and the editors work hard on researching various cancers. Their focus is on getting information about how to combat cancer out to the public. The company is frequently cited in many peers reviewed research journals. An impact factor is a measure of how often work is cited. Oncotarget received an impact factor score of 5.008 for the years 2015 through 2016. What this means is they have received over 10,000 citations for 2015 through 2016.

Source: http://www.bioxbio.com/if/html/ONCOTARGET.html. They are a company at the forefront of cancer research.

Their business is located in Albany, New York. The journal has been being published since 2010. You can contact them by email at [email protected], by fax at 716-508-8254 or by phone at 1-800-922-0957.